Organ preservation surgery for patients with T4a laryngeal cancer

Head and Neck
  • 31 Downloads

Abstract

Purpose

Surgical preservation of laryngeal function is very challenging in patients with advanced SCCL, especially those of stage T4a. The purpose of this study was to assess the feasibility of organ preservation surgery for patients with T4a squamous cell carcinoma of the larynx (SCCL).

Methods

We enrolled 32 patients with T4a SCCL and performed organ preservation surgery on them. Surgical details and perioperative morbidity were described, functional and oncologic outcomes were also evaluated.

Results

All patients underwent supracricoid subtotal laryngectomy with unilateral or bilateral neck dissection, restoring laryngeal function via direct anastomosis of the cricoid cartilage and tongue base. The patients recovered well and exhibited relatively acceptable survival duration, with a 5-year overall survival rate of 62.5%. Most patients commenced oral intake within 2 weeks, and aspiration was commonly observed. Subjective functional outcomes indicated a relatively acceptable swallowing function and voice quality.

Conclusion

Our retrospective analysis of 32 patients with T4a SCCL showed that successful organ preservation surgery is safe and reliable, and associated with a relatively acceptable disease-free survival, normal swallowing function, and acceptable voice quality. More patients with T4a SCCL who wish to preserve the larynx should be considered for organ preservation surgery.

Keywords

T4a laryngeal cancer Organ preservation Total laryngectomy Chemoradiation 

Notes

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

The study was approved the ethical standards of the institutional research committee and conducted in accordance to the principles of the Declaration of Helsinki (1964).

Informed consent

General informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Zhang SS, Xia QM, Zheng RS et al (2015) Laryngeal cancer incidence and mortality in China, 2010. J Cancer Res Ther Suppl 2:C143-8Google Scholar
  2. 2.
    Forte T, Niu J, Lockwood GA, Bryant HE (2012) Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992–2009. Cancer Causes Control 23:1343–1348CrossRefPubMedGoogle Scholar
  3. 3.
    Forastiere AA, Weber RS, Trotti A (2015) Organ preservation for Advanced Larynx Cancer: issues and outcomes. J Clin Oncol 33:3262–3268CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Chen AY, Frankowski R, Bishop-Leone J et al (2001) The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 127:870–876PubMedGoogle Scholar
  5. 5.
    Rosen CA, Lee AS, Osborne J, Zullo T, Murry T (2001) Development and validation of the voice handicap index-10. Laryngoscope 11:1549–1556Google Scholar
  6. 6.
    Cmelak AJ, Li S, Goldwasser MA et al (2007) Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 25:3971–3977CrossRefPubMedGoogle Scholar
  7. 7.
    Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31:845–852CrossRefPubMedGoogle Scholar
  8. 8.
    Beitler JJ, Muller S, Grist WJ et al (2010) Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy. J Clin Oncol 28:2318–2322CrossRefPubMedGoogle Scholar
  9. 9.
    Lefebvre JL, Pointreau Y, Rolland F et al (2013) Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol 31:853–859CrossRefPubMedGoogle Scholar
  10. 10.
    Karatzanis AD, Psychogios G, Waldfahrer F et al (2014) Management of locally advanced laryngeal cancer.J Otolaryngol. Head Neck Surg 43:4Google Scholar
  11. 11.
    Dziegielewski PT, O’Connell DA, Klein M et al (2012) Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg Suppl 1:S56-64Google Scholar
  12. 12.
    Rosenthal DI, Mohamed AS, Weber RS et al (2015) Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a 3-decade survey. Cancer 121:1608–1619CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Francis E, Matar N, Khoueir N, Nassif C, Farah C, Haddad A (2014) T4a laryngeal cancer survival: retrospective institutional analysis and systematic review. Laryngoscope 124:1618–1623CrossRefPubMedGoogle Scholar
  14. 14.
    Timme DW, Jonnalagadda S, Patel R, Rao K, Robbins KT (2015) Treatment selection for T3/T4a laryngeal cancer: chemoradiation versus primary surgery. Ann Otol Rhinol Laryngol 124:845–851CrossRefPubMedGoogle Scholar
  15. 15.
    Taberna M, Rullan AJ, Hierro C et al (2015) Late toxicity after radical treatment for locally advanced head and neck cancer. Oral Oncol 51:795–799CrossRefPubMedGoogle Scholar
  16. 16.
    Canis M, Ihler F, Martin A, Wolff HA, Matthias C, Steiner W (2013) Organ preservation in T4a laryngeal cancer: is transoral laser microsurgery an option? Eur Arch Otorhinolaryngol 270:2719–2727CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Otorhinolaryngology-Head and Neck Surgery, Changhai HospitalSecond Military Medical UniversityShanghaiChina

Personalised recommendations